Figure 4 | Scientific Reports

Figure 4

From: ER+/PR− phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer

Figure 4The alternative text for this image may have been generated using AI.

Kaplan–Meier curves of breast cancer-specific survival (A) and overall survival (B) based on hormone receptor status for stage III inflammatory breast cancer patients with ER-positive and HER2-negative after standard trimodality treatment.

Back to article page